Our study contributes to the growing body of knowledge on CAMRQ syndrome by expanding on the clinical and genetic aspects of a novel in‐frame deletion variant in the ATP8A2 gene. This evidence concerns the gene ATP8A2 and cerebellar ataxia, intellectual disability, and dysequilibrium.